Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

NeuroImage

Volumn 42, Issue 2, 2008, Pages 869-878

  Chang, Linda ^a   Wang, Gene Jack ^b   Volkow, Nora D ^c   Ernst, Thomas ^a   Telang, Frank ^b   Logan, Jean ^b   Fowler, Joanna S ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cognition; Dementia; Dopamine; HIV; PET; Transporters

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; RACLOPRIDE C 11;

ADULT; ARTICLE; CAUDATE NUCLEUS; CELL DAMAGE; CLINICAL ARTICLE; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STRUCTURAL EQUATION MODELING; TOBACCO DEPENDENCE;

ADULT; AIDS DEMENTIA COMPLEX; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; CORPUS STRIATUM; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 47949131993     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.05.011     Document Type: Article

References (43)

1. American Academy of Neurology AIDS Task Force Working Group. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type-1. Neurology 41 (1991) 778-785
2. Avison M.J., Nath A., Greene-Avison R., Schmitt F.A., Greenberg R.N., and Berger J.R. Neuroimaging correlates of HIV-associated BBB compromise. J. Neuroimmunol. 157 (2004) 140-146
3. Berger J.R., Kumar M., Kumar A., Fernandez J., and Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. Acquir. Immune. Defic. Syndr. 8 (1994) 67-71
4. Cysique L.A., Brew B.J., Halman M., Catalan J., Sacktor N., Price R.W., Brown S., Atkinson J.H., Clifford D.B., Simpson D., Torres G., Hall C., Power C., Marder K., McArthur J.C., Symonds W., and Romero C. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J. Acquir. Immune. Defic. Syndr. 39 (2005) 426-429
5. Czub S., Koutsilieri E., Sopper S., Czub M., Stahl-Hennig C., Muller J., Pedersen V., Gsell W., Heeney J., Gerlach M., Gosztonyi G., Riederer P., and ter Meulen V. Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol. (Berlin) 101 (2001) 85-91
6. Czub S., Czub M., Koutsilieri E., Sopper S., Villinger F., Muller J., Stahl-Hennig C., Riederer P., Ter Meulen V., and Gosztonyi G. Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol. (Berl) 107 (2004) 216-226
7. Factor S., Podskalny G., and Barron K. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. J. Neurol. Sci. 127 (1994) 114-120
8. Gelman B., Spencer J., Holzer C., and Soukup V. Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J. Neuroimmune. Pharmacol. 1 4 (2006) 410-420
9. Hinkin C., Castellon S., Hardy D., Farinpour R., Newton T., and Singer E. Methylphenidate improves HIV-1-associated cognitive slowing. J. Neuropsychiatry Clin. Neurosci. 13 (2001) 248-254
10. Howell D. Statistical Methods for Psychology. 4th Edition (2001), Wadsworth Publishing ed
11. Hriso E., Kuhn T., Masdeu J., and Grundman M. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am. J. Psychiatry 148 (1991) 1558-1561
12. Jernigan T., Gamst A., Archibald S., Fennema-Notestine C., Mindt M., Marcotte T., Heaton R., Ellis R., and Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Ame. J. Psychiatry 162 (2005) 1461-1472
13. Kaul M., Garden G., and Lipton S. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410 (2001) 988-994
14. Khan Z., Koulen P., Rubinstein M., Grandy D., and Goldman-Rakic P. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1964-1969
15. Kure K., Weidenheim K.M., Lyman W.D., and Dickson D.W. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. ACTA Neuropathol. (Berlin) 80 (1990) 393-400
16. Larsson M., Hagberg L., Forsman A., and Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J. Neurosci. Res. 28 (1991) 406-409
17. Law W.A., Martin A., Mapou R.L., Roller T.L., Salazar A.M., Temoshok L.R., and Rundell J.R. Working Memory in individuals with HIV infection. J. Clin. Exp. Neuropsychol. 16 (1994) 173-182
18. Lefkowitz S.S., Vaz A., Lincoln J., Cain T., Brown D.J., and Lefkowitz D.L. Alteration of macrophage functions by cocaine. Adv. Exp. Med. Biol. 402 (1996) 135-144
19. Logan J., Volkow N., Fowler J., Wang G., Dewey S., MacGregor R., Schlyer D., Gatley S., Pappas N., King P., et al. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J. Cereb. Blood Flow Metab. 14 (1994) 995-1010
20. Mao J.T., Huang M., Wang J., Sharma S., Tashkin D.P., and Dubinett S.M. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol. 172 (1996) 217-223
21. Marie R., Barre L., Dupuy B., Viader F., Defer G., and Baron J. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci. Lett. 260 (1999) 77-80
22. Mash D.C., Pablo J., Ouyang Q., Hearn W.L., and Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 81 (2002) 292-300
23. Miller E.N., Selnes O.A., McArthur J.C., Satz P., Becker J.T., Cohen B.A., Sheridan K., Machado A.M., Van Gorp W.G., and Visscher B. Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 40 (1990) 197-203
24. Miller G., Staley J., Heilman C., Perez J., Mash D., Rye D., and Levey A. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann. Neurol. 41 (1997) 530-539
25. Moore D.J., Masliah E., Rippeth J.D., Gonzalez R., Carey C.L., Cherner M., Ellis R.J., Achim C.L., Marcotte T.D., Heaton R.K., and Grant I. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. Aids 20 (2006) 879-887
26. Moszczynska A., Fitzmaurice P., Ang L., Kalasinsky K.S., Schmunk G.A., Peretti F.J., Aiken S.S., Wickham D.J., and Kish S.J. Why is parkinsonism not a feature of human methamphetamine users?. Brain 127 (2004) 363-370
27. Meisner F., Scheller C., Kneitz S., Sopper S., Neuen-Jacob E., Riederer P., Meulen V., and Koutsilieri E. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology (2007) Oct 31. [Electronic publication ahead of print]
28. Nath A., Anderson C., Jones M., Maragos W., Booze R., Mactutus C., Bell J., Hauser K., and Mattson M. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J. Psychopharmacol. 14 (2000) 222-227
29. Reyes M., Faraldi F., Senseng C., Flowers C., and Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol. (Berlin) 82 (1991) 39-44
30. Roth M.D., Tashkin D.P., Choi R., Jamieson B.D., Zack J.A., and Baldwin G.C. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J. Infect. Dis. 185 (2002) 701-705
31. Rottenberg D.A., Sidtis J.J., Strother S.C., Schaper K.A., Anderson J.R., Nelson M.J., and Price R.W. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J. Nucl. Med. 37 (1996) 1133-1141
32. Sardar A., Czudek C., and Reynolds G. Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. NeuroReport 7 (1996) 910-912
33. Scheel-Kruger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurologic Scandanavia Suppl 107 (1986) 1-54
34. Scheller C., Sopper S., Jassoy C., ter Meulen V., Riederer P., and Koutsilieri E. Dopamine activates HIV in chronically infected T lymphoblasts. J. Neural Transm. 107 (2000) 1483-1489
35. Schifitto G., Navia B., Yiannoutsos C., Marra C., Chang L., Ernst T., Jarvik J., Miller E., Singer E., Ellis R., Kolson D., Simpson D., Nath A., Berger J., Shriver S., Millar L., Colquhoun D., Lenkinski R., Gonzalez R., Lipton S., and Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; HIV MRS Consortium. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 21 14 (2007) 1877-1886
36. Simes R.J. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73 (1986) 751-754
37. Volkow N., Ding Y., Fowler J., Wang G., Logan J., Gatley S., Hitzemann R., Smith G., Fields S., and Gur R. Dopamine transporters decrease with age. J. Nucl. Med. 37 (1996) 554-559
38. Volkow N., Fowler J., Gatley S., Logan J., Wang G., Ding Y., and Dewey S. PET evaluation of the dopamine system of the human brain. J. Nucl. Med. 37 (1996) 1242-1256
39. Volkow N.D., Fowler J.S., and Wang G.J. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J. Psychopharmacol. 13 (1999) 337-345
40. Volkow N., Logan J., Fowler J., Wang G., Gur R., Wong C., Felder C., Gatley S., Ding Y., Hitzemann R., and Pappas N. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am. J. Psychiatry 157 (2000) 75-80
41. Volkow N., Chang L., Wang G., Fowler J., Leonido-Yee M., Franceschi D., Sedler M., Gatley S., Hitzemann R., Ding Y., Logan J., Wong C., and Miller E. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158 (2001) 377-382
42. Wang G.J., Volkow N.D., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., Logan J., and Pappas N.R. Cocaine abusers do not show loss of dopamine transporters with age. Life Sci. 61 (1997) 1059-1065
43. Wang G., Chang L., Volkow N., Telang F., Logan J., Ernst T., and Fowler J. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127 (2004) 2452-2458